erasmusmc.nl Background Cystic fibrosis (CF) lung disease is characterised by ... slice thickness equal or less than 1.5 mm; imaging of the entire lung parenchyma and no major artefacts. The first ...
Chronic airways diseases, including asthma, COPD and cystic ... CT imaging has made an important contribution to the diagnosis and management of airways disease for many years. It allows the ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...
Patients with bronchiectasis in China have a high disease burden and a low rate of use of evidence-based treatments.
BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...
The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF ... leading to chronic infections and bronchiectasis with resulting marked decline ...
Background: The prevalence of bronchiectasis among adult Aboriginal Australians is higher than that of non-Aboriginal Australians. However, despite evidence to suggest higher prevalence of ...
Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease. 12 min read What Is Cystic Fibrosis? Cystic ...
After hours: February 3 at 6:38:50 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback